Laboratorio Clinico Irizarry Guasch INC
Laboratorio Clinico Irizarry Guasch INC was paid $1.24M by Medicaid between Jan 2018 and Dec 2024, across 49 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 18% of everything it billed.
MAYAGUEZ, PR 00680
Next to other Clinical Medical Laboratory providers in Puerto Rico
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,929 | $97K | |
| 2019 | 8,030 | $75K | |
| 2020 | 9,713 | $119K | |
| 2021 | 12,624 | $235K | |
| 2022 | 9,070 | $172K | |
| 2023 | 14,329 | $171K | |
| 2024incomplete | 29,156 | $365K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 18% | 4,985 | 3,960 | $217K |
| 84443 | Thyroid stimulating hormone (TSH) | 10% | 7,411 | 5,733 | $128K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 10.0% | 15,270 | 11,276 | $123K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 8.6% | 4,496 | 4,065 | $106K |
| 80061 | Lipid panel | 7.9% | 7,091 | 5,424 | $97K |
| 80053 | Comprehensive metabolic panel | 6.4% | 7,248 | 5,557 | $79K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 5.2% | 2,170 | 1,499 | $64K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 4.5% | 2,269 | 1,724 | $56K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.3% | 4,403 | 1,504 | $53K |
| 81000 | 2.7% | 9,959 | 7,647 | $33K | |
| 86328 | 2.6% | 1,744 | 1,592 | $33K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.5% | 3,081 | 2,264 | $31K |
37 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.4% | 585 | $29K |
| 82274 | 2.3% | 1,711 | $28K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.0% | 2,835 | $24K |
| 36415 | Collection of venous blood by venipuncture | 1.6% | 7,287 | $19K |
| 86738 | 1.2% | 874 | $15K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.0% | 273 | $13K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.0% | 272 | $13K |
| 82043 | <1% | 1,620 | $10K | |
| 84153 | <1% | 453 | $9K | |
| 80074 | <1% | 137 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 767 | $7K |
| 84439 | <1% | 521 | $5K | |
| 85651 | <1% | 1,279 | $5K | |
| 86592 | <1% | 1,035 | $5K | |
| 85730 | <1% | 623 | $4K | |
| 84436 | <1% | 454 | $3K | |
| 86803 | <1% | 199 | $3K | |
| 87088 | <1% | 341 | $3K | |
| 85610 | <1% | 649 | $3K | |
| 82570 | <1% | 407 | $2K | |
| 82607 | <1% | 132 | $2K | |
| 82947 | <1% | 378 | $1K | |
| 83655 | <1% | 101 | $1K | |
| 86140 | <1% | 174 | $958.47 | |
| 84207 | <1% | 31 | $944.18 | |
| 82950 | <1% | 145 | $747.12 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 37 | $611.63 |
| 82270 | <1% | 100 | $427.40 | |
| 84550 | <1% | 48 | $225.18 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 22 | $174.38 |
| 83540 | <1% | 12 | $121.20 | |
| 84479 | <1% | 12 | $82.86 | |
| 85018 | <1% | 46 | $54.81 | |
| 82565 | <1% | 13 | $50.31 | |
| 85014 | <1% | 34 | $38.70 | |
| 3044F | 0% | 24 | $0.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 93 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Laboratorio Clinico Irizarry Guasch INC | Lajas, PR | $2.00M |
| Laboratorio Clinico Irizarry Guasch INC | Mayaguez, PR | $1.64M |
| Laboratorio Clinico Irizarry Guasch INC | Lajas, PR | $1.53M |
| Laboratorio Clinico Irizarry Guasch INC | San Sebastian, PR | $1.50M |
| Lab Clinico Irizarry Guasch INC | Mayaguez, PR | $1.11M |
| Laboratorio Clinico Irizarry Guasch INC | San German, PR | $1.03M |
| Laboratorio Clinico Irizarry Guasch INC | Cabo Rojo, PR | $723K |
| Laboratorio Clinico Irizarry Guaschinc | Aguadilla, PR | $620K |
| Nuevo Smile Dental Care | Nuevo, CA | $546K |
| Laboratorio Clinico Irizarry Guasch INC | Aguadilla, PR | $542K |
| Laboratorio Clinico Anexo Irizarry Guasch INC | San Sebastian, PR | $353K |
| Jose M Sanchez Dental Corporation | Pomona, CA | $59K |
| Grupo Otorrinolaringologico De PR CSP | Bayamon, PR | $21K |
| Jose Manuel Sanchez MD PA | Coral Gables, FL | $62.40 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.